EMA Lapsed: Posaconazole SP (posaconazole) — Schering-Plough Europe

View source ↗

Summary

EMA status shows Posaconazole SP has lapsed; therapeutic areas include candidiasis, mycoses, coccidioidomycosis, and aspergillosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aspergillosis
• Candidiasis
• Coccidioidomycosis
• Mycoses

Drugs mentioned

• Posaconazole SP (posaconazole)

Snippet

Status: Lapsed. Therapeutic area: Candidiasis;Mycoses;Coccidioidomycosis;Aspergillosis. MAH: Schering-Plough Europe. Decision date: 04/12/2008